Bioperfectus Showcases Automated Nucleic Acid Extraction Systems and Solutions

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) is showcasing its wide range of dependable solutions for meeting every laboratory's PCR needs at AACC 2023. The company is also highlighting its automatic nucleic acid extraction systems alongside its range of RUO products and raw materials for life science solutions.

Bioperfectus Total PCR Solution offers holistic products of extraction systems, extraction reagents, real-time PCR systems, and RT-PCR reagents. These products cover PCR detection workflow and assure the users with reassuring results by validated performance. Total PCR Solutions can improve operational and cost efficiency, optimize workflow and improve performance at every opportunity. At AACC 2023, Bioperfectus is also presenting its comprehensive range of PCR-related products and raw materials that exhibit excellent stability to ensure accurate and reliable experimental results.

Image: The Total PCR Solution can improve operational and cost efficiency for labs (Photo courtesy of Bioperfectus)

Visitors to the Bioperfectus booth at AACC 2023 can get an early look at the company’s solutions designed to help address the present as well as future needs of laboratories. The company’s new SSNP-2000B nucleic acid extraction system being exhibited at the show integrates advanced technologies such as machine, electricity and computer software to enable the automatic nucleic acid extraction of a maximum of 32 samples at one time. In addition, the new SAW-48 in-vitro diagnostic medical device being highlighted at the show combines sample loading, nucleic acid purification, and PCR setup functions (PCR master mix preparation and nucleic acid pipetting) into one instrument. It has the same basic functions as SAW-96 but is smaller and lighter. Bioperfectus is also showcasing the STC-96A Plus Real-Time PCR System which is a more flexible, efficient and reliable breakthrough in real-time PCR analysis of gene expression and genetic variation. It allows users to apply two different PCR assays on just one instrument with separate-controlled programs.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.